Benzinga · Sep 11, 2026
UBS Maintains Buy on Labcorp Holdings, Raises Price Target to $380
UBS analyst Kevin Caliendo maintains Labcorp Holdings (NYSE:LH) with a Buy and raises the price target from $361 to $380.
NYSE · LH
Labcorp Holdings Inc.
Healthcare · Medical - Equipment & Services
$323.97
Up+$8.66 (+2.75%)
Updated Sep 16, 2026, 11:40 AM
SID Score
6.9/10
Composite research score
Smart Money
58/100
Neutral
- Market cap
- 21.94B
- P/E ratio
- 25.71
- Dividend yield
- 0.89%
- 52-week range
- $245.00 – $341.80
- Volume
- 878.29K
- Avg. volume
- 774.33K
Price performance
LH price history
1M range · 0 trading sessions · Daily adjusted prices
LH does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
Latest LH news
The latest Smart Investors Daily articles mentioning LH.
Stock researchCompany · Overview
LH research
Overview
Company profile and research snapshot.
Company profile
Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- Buy
- Average target
- $314.43
- Implied upside
- —
- Analysts
- 29
| Date | Firm | Rating | Target |
|---|---|---|---|
| Sep 11, 2026 | UBS | Buy | — |
| Sep 11, 2026 | Barclays | Equal-Weight | — |
| Aug 4, 2026 | Piper Sandler | Neutral | — |
| Aug 3, 2026 | JP Morgan | Overweight | — |
| Jul 31, 2026 | Truist Securities | Buy | — |
News briefing
No generated briefing is available yet.
Benzinga · Sep 11, 2026
Barclays Maintains Equal-Weight on Labcorp Holdings, Raises Price Target to $330
Barclays analyst Luke Sergott maintains Labcorp Holdings (NYSE:LH) with a Equal-Weight and raises the price target from $320 to $330.
SeekingAlpha · Sep 11, 2026
Labcorp Holdings Inc. (LH) Analyst/Investor Day Transcript
Labcorp Holdings Inc. (LH) Analyst/Investor Day September 10, 2026 9:00 AM EDTCompany ParticipantsDewey Steadman - Senior Vice President of Investor...
Benzinga · Sep 10, 2026
Labcorp Bets Big on AI, Specialty Testing to Drive Growth Through 2029
Labcorp shares its strategic priorities and reaffirms 2026 guidance at its Investor Day, forecasting steady revenue growth through 2029.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
